Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: A nationwide cohort study

Heart Rhythm

Volumn 11, Issue 11, 2014, Pages 1941-1947

  Chao, Tze Fan ^a,b   Huang, Yen Chang ^c   Liu, Chia Jen ^a,b   Chen, Su Jung ^a,b   Wang, Kang Ling ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Tuan, Ta Chuan ^a,b   Chen, Tzeng Ji ^a   Hsieh, Ming Hsiung ^d   Lip, Gregory Y H ^e   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; CHA2DS2 VASc score; Gender; Myocardial infarction; Subclinical atherosclerosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; ATRIAL FIBRILLATION; AUTOIMMUNE DISEASE; CARDIOVASCULAR RISK; CHA2DS2 VASC SCORE; CHADS2 SCORE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DYSLIPIDEMIA; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; AGED; CASE CONTROL STUDY; COMPLICATION; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX; TAIWAN;

ADULT; AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TAIWAN;

EID: 84930926059     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.08.003     Document Type: Article

References (31)

1. Conen, D., Tedrow, U.B., Koplan, B.A., Glynn, R.J., Buring, J.E., Albert, C.M., Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 119 (2009), 2146–2152.
2. Alonso, A., Lopez, F.L., Matsushita, K., Loehr, L.R., Agarwal, S.K., Chen, L.Y., Soliman, E.Z., Astor, B.C., Coresh, J., Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123 (2011), 2946–2953.
3. Schoen, T., Pradhan, A.D., Albert, C.M., Conen, D., Type 2 diabetes mellitus and risk of incident atrial fibrillation in women. J Am Coll Cardiol 60 (2012), 1421–1428.
4. Chao, T.F., Hung, C.L., Chen, S.J., Wang, K.L., Chen, T.J., Lin, Y.J., Chang, S.L., Lo, L.W., Hu, Y.F., Tuan, T.C., Chen, S.A., The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168 (2013), 4027–4032.
5. Heeringa, J., van der Kuip, D.A., Hofman, A., Kors, J.A., van Rooij, F.J., Lip, G.Y., Witteman, J.C., Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med 167 (2007), 382–387.
6. Chen, L.Y., Foo, D.C., Wong, R.C., Seow, S.C., Gong, L., Benditt, D.G., Ling, L.H., Increased carotid intima-media thickness and arterial stiffness are associated with lone atrial fibrillation. Int J Cardiol 168 (2013), 3132–3134.
7. Soliman, E.Z., Safford, M.M., Muntner, P., Khodneva, Y., Dawood, F.Z., Zakai, N.A., Thacker, E.L., Judd, S., Howard, V.J., Howard, G., Herrington, D.M., Cushman, M., Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 174 (2014), 107–114.
8. Lip, G.Y., Nieuwlaat, R., Pisters, R., Lane, D.A., Crijns, H.J., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137 (2010), 263–272.
9. Camm, A.J., Kirchhof, P., Lip, G.Y., et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31 (2010), 2369–2429.
10. Camm, A.J., Lip, G.Y., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S.H., Hindricks, G., Kirchhof, P., 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33 (2012), 2719–2747.
11. Chen, S.J., Liu, C.J., Chao, T.F., Wang, K.L., Chen, T.J., Chou, P., Wang, F.D., Lin, S.J., Chiang, C.E., Dental scaling and atrial fibrillation: a nationwide cohort study. Int J Cardiol 168 (2013), 2300–2303.
12. Lin, L.J., Cheng, M.H., Lee, C.H., Wung, D.C., Cheng, C.L., Kao Yang, Y.H., Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation—a nationwide descriptive study in Taiwan. Clin Ther 30 (2008), 1726–1736.
13. Chang, C.H., Lee, Y.C., Tsai, C.T., Chang, S.N., Chung, Y.H., Lin, M.S., Lin, J.W., Lai, M.S., Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease. Atherosclerosis 232 (2014), 224–230.
14. Chen, Z.Y., Chiang, C.H., Huang, C.C., Chung, C.M., Chan, W.L., Huang, P.H., Lin, S.J., Chen, J.W., Leu, H.B., The association of tooth scaling and decreased cardiovascular disease: a nationwide population-based study. Am J Med 125 (2012), 568–575.
15. Chu, S.Y., Chen, Y.J., Liu, C.J., Tseng, W.C., Lin, M.W., Hwang, C.Y., Chen, C.C., Lee, D.D., Chen, T.J., Chang, Y.T., Wang, W.J., Liu, H.N., Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med 126 (2013), 982–988.
16. Lee, W.H., Hsu, P.C., Chu, C.Y., Su, H.M., Lee, C.S., Yen, H.W., Lin, T.H., Voon, W.C., Lai, W.T., Sheu, S.H., Cardiovascular events in patients with atherothrombotic disease: a population-based longitudinal study in Taiwan. PLoS One, 9, 2014, e92577.
17. Cheng, C.L., Kao, Y.H., Lin, S.J., Lee, C.H., Lai, M.L., Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20 (2011), 236–242.
18. Jahangir, A., Lee, V., Friedman, P.A., Trusty, J.M., Hodge, D.O., Kopecky, S.L., Packer, D.L., Hammill, S.C., Shen, W.K., Gersh, B.J., Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 115 (2007), 3050–3056.
19. Kopecky, S.L., Gersh, B.J., McGoon, M.D., Whisnant, J.P., Holmes, D.R. Jr, Ilstrup, D.M., Frye, R.L., The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 317 (1987), 669–674.
20. Brand, F.N., Abbott, R.D., Kannel, W.B., Wolf, P.A., Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 254 (1985), 3449–3453.
21. Jouven, X., Desnos, M., Guerot, C., Ducimetiere, P., Idiopathic atrial fibrillation as a risk factor for mortality: the Paris Prospective Study I. Eur Heart J 20 (1999), 896–899.
22. Weijs, B., de Vos, C.B., Tieleman, R.G., Peeters, F.E., Limantoro, I., Kroon, A.A., Cheriex, E.C., Pisters, R., Crijns, H.J., The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation. Europace 15 (2013), 18–23.
23. Benjamin, E.J., Levy, D., Vaziri, S.M., D'Agostino, R.B., Belanger, A.J., Wolf, P.A., Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271 (1994), 840–844.
24. Schmitt, J., Duray, G., Gersh, B.J., Hohnloser, S.H., Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 30 (2009), 1038–1045.
25. Willeit, K., Pechlaner, R., Egger, G., Weger, S., Oberhollenzer, M., Willeit, J., Kiechl, S., Carotid atherosclerosis and incident atrial fibrillation. Arterioscler Thromb Vasc Biol 33 (2013), 2660–2665.
26. Aberg, H., Atrial fibrillation, I: A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 185 (1969), 373–379.
27. Alasady, M., Shipp, N.J., Brooks, A.G., Lim, H.S., Lau, D.H., Barlow, D., Kuklik, P., Worthley, M.I., Roberts-Thomson, K.C., Saint, D.A., Abhayaratna, W., Sanders, P., Myocardial infarction and atrial fibrillation: importance of atrial ischemia. Circ Arrhythm Electrophysiol 6 (2013), 738–745.
28. Aviles, R.J., Martin, D.O., Apperson-Hansen, C., Houghtaling, P.L., Rautaharju, P., Kronmal, R.A., Tracy, R.P., Van Wagoner, D.R., Psaty, B.M., Lauer, M.S., Chung, M.K., Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003), 3006–3010.
29. Ridker, P.M., Rifai, N., Stampfer, M.J., Hennekens, C.H., Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000), 1767–1772.
30. Chien, K.L., Su, T.C., Hsu, H.C., Chang, W.T., Chen, P.C., Chen, M.F., Lee, Y.T., Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol 139 (2010), 173–180.
31. Ueshima, H., Sekikawa, A., Miura, K., Turin, T.C., Takashima, N., Kita, Y., Watanabe, M., Kadota, A., Okuda, N., Kadowaki, T., Nakamura, Y., Okamura, T., Cardiovascular disease and risk factors in Asia: a selected review. Circulation 118 (2008), 2702–2709.